BIOSANAPHARMA
BIOSANAPHARMA
Social Links:
Industry:
Biopharma Health Care Medical
Founded:
2012-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.biosanapharma.com
Total Employee:
1+
Status:
Active
Contact:
31-610026742
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Official Site Inspections
http://www.biosanapharma.com Semrush global rank: 6.98 M Semrush visits lastest month: 656
- Host name: oxygen.schuttelaar.net
- IP address: 188.166.112.179
- Location: Amsterdam Netherlands
- Latitude: 52.352
- Longitude: 4.9392
- Timezone: Europe/Amsterdam
- Postal: 1098
More informations about "BiosanaPharma"
Our team & approach - BiosanaPharma
The Biosanapharma team has multiple years of experience with biosimilar development and fully documented GMP continuous manufacturing, including interactions with FDA/EMA. ... - CEO. Ard has wide experience in project and …See details»
BiosanaPharma - Crunchbase Company Profile
BiosanaPharma is located in Leiden, Zuid-Holland, The Netherlands. Who are BiosanaPharma 's competitors? Alternatives and possible competitors to BiosanaPharma may include Genrobotics Medical & Mobility , Pihlajalinna , …See details»
BiosanaPharma - LinkedIn
BiosanaPharma has developed a highly flexible, comprehensive Continuous Manufacturing (CM) automation platform, suitable for all relevant GMP production scales (50L, 500L, and 2000L).See details»
BiosanaPharma - Contacts, Employees, Board Members, Advisors …
BiosanaPharma is a company that produces medical products for healthcare industries.See details»
Biosanapharma BV - Drug pipelines, Patents, Clinical trials - Synapse
Explore Biosanapharma BV with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Immune System Diseases, Technology Platform:Monoclonal antibody, …See details»
Contact - BiosanaPharma
Australia Biosana Pty Ltd. National Innovation Centre Australian Technology Park Suite 145, 4 Cornwallis Street Eveleigh NSW 2015 Australia. send mailSee details»
BiosanaPharma Company Profile 2024: Valuation, Funding
BiosanaPharma was founded in 2012. Where is BiosanaPharma headquartered? BiosanaPharma is headquartered in Leiden, Netherlands. What is the size of BiosanaPharma? BiosanaPharma …See details»
Biosana Pharma - VentureRadar
The second product is a biosimilar of denosumab, for osteoporosis and cancer-induced bone loss;development starting in 2018. We will also develop oral formulations of omalizumab and …See details»
BiosanaPharma - Products, Competitors, Financials, Employees ...
BiosanaPharma has completed a pharmacokinetic (PK) study showing that AVT23's bioavailability, safety, tolerability and immunogenicity were comparable to those of Xolair. In …See details»
BiosanaPharma Company Profile - Office Locations, Competitors
BiosanaPharma Summary. Company Summary. Overview. BiosanaPharma is a biopharmaceutical company focused on reducing the biosimilars of monoclonal antibody …See details»
BiosanaPharma - LinkedIn
BiosanaPharma | 1,158 followers on LinkedIn. Making biologics affordable and accessible for all patients | BiosanaPharma is transforming the production of mAb biologics with a continuous …See details»
Alvotech Enters Exclusive Global Licensing Agreement with …
Feb 2, 2022 Reykjavik, Iceland & Leiden, The NetherlandS (February 2, 2022) — Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the …See details»
BiosanaPharma And A*STARs Bioprocessing Technology Institute ...
Nov 15, 2019 BiosanaPharma’s “3C process” offers a 90% reduction in the cost of developing and manufacturing EMA/FDA quality mAbs. The 3C process is a fully-continuous, single use, …See details»
BiosanaPharma Gets Approval To Start Phase I Clinical Trial For A ...
Feb 28, 2019 BiosanaPharma gets approval to start phase I clinical trial for a biosimilar version of omalizumab, the first monoclonal antibody produced with a fully continuous …See details»
Alvotech agreement with Biosana - Leiden Bio Science Park
Feb 8, 2022 REYKJAVIK, ICELAND & LEIDEN, THE NETHERLANDS (February 2, 2022) — Alvotech Holdings S.A.(“Alvotech”), a global biopharmaceutical company focused solely on the …See details»
Alvotech Enters Exclusive Global Licensing Agreement with …
Feb 2, 2022 About BiosanaPharma. BiosanaPharma is a biotechnology company with operations in Australia, the Netherlands and Singapore. The company is headed by a team of …See details»
Our technology and products | BiosanaPharma
Once all systems function together as intended, the continuous manufacturing (CM) train is transferred to your biomanufacturing facility for installation and commissioning, overseen by …See details»
News - BiosanaPharma
BiosanaPharma’s “3C process” offers a 90% reduction in the cost of developing and manufacturing EMA/FDA quality mAbs. The 3C process is a fully-continuous, single use, small …See details»
News - BiosanaPharma
BiosanaPharma and Alvotech close deal on omalizumab biosimilar. In the press 26 October 2021. Simplifying the bioprocessing journey. In the press 08 July 2020. One Virtual Biotech's …See details»